These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 36449287)
1. Association of Perceived Benefit or Burden of Research Participation With Participants' Withdrawal From Cancer Clinical Trials. Ulrich CM; Ratcliffe SJ; Zhou Q; Huang L; Hochheimer C; Gordon T; Knafl K; Miller V; Naylor MD; Schapira MM; Richmond TS; Grady C; Mao JJ JAMA Netw Open; 2022 Nov; 5(11):e2244412. PubMed ID: 36449287 [TBL] [Abstract][Full Text] [Related]
2. Experiences of Patients After Withdrawal From Cancer Clinical Trials. Ulrich CM; Knafl K; Foxwell AM; Zhou Q; Paidipati C; Tiller D; Ratcliffe SJ; Wallen GR; Richmond TS; Naylor M; Gordon TF; Grady C; Miller V JAMA Netw Open; 2021 Aug; 4(8):e2120052. PubMed ID: 34374772 [TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
4. Rates of and Factors Associated With Patient Withdrawal of Consent in Cancer Clinical Trials. Hillman SL; Jatoi A; Strand CA; Perlmutter J; George S; Mandrekar SJ JAMA Oncol; 2023 Aug; 9(8):1041-1047. PubMed ID: 37347469 [TBL] [Abstract][Full Text] [Related]
5. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
6. Caregiver Perspectives on the Benefits, Burdens, and Moral Distress of Participation in Cancer Clinical Trials. Paidipati CP; Foxwell AM; Mooney-Doyle K; Tiller D; Pinto-Martin J; Ulrich CM J Fam Nurs; 2023 Feb; 29(1):89-98. PubMed ID: 35611586 [TBL] [Abstract][Full Text] [Related]
7. Developing a Model of the Benefits and Burdens of Research Participation in Cancer Clinical Trials. Ulrich CM; Knafl KA; Ratcliffe SJ; Richmond TS; Grady C; Miller-Davis C; Wallen GR AJOB Prim Res; 2012; 3(2):10-23. PubMed ID: 24748992 [TBL] [Abstract][Full Text] [Related]
8. Perceived Benefits and Burdens of Participation for Caregivers of Cancer Patients in Hospice Clinical Trials: A Pilot Study. Oliver DP; Benson JJ; Ulrich C; Washington KT; Rolbiecki AJ; White P; Smith JB; Lero C; Landon OJ; Demiris G J Pain Symptom Manage; 2021 Jun; 61(6):1147-1154. PubMed ID: 33166583 [TBL] [Abstract][Full Text] [Related]
9. The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices. Peterson IS; Mazzella AJ; Belter LT; Curry MA; Cruz RE; Jarecki J Neurol Ther; 2022 Sep; 11(3):1167-1181. PubMed ID: 35635603 [TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Withdrawal From Maintenance Dialysis: A Case-Control Analysis. Wetmore JB; Yan H; Hu Y; Gilbertson DT; Liu J Am J Kidney Dis; 2018 Jun; 71(6):831-841. PubMed ID: 29331476 [TBL] [Abstract][Full Text] [Related]
11. Effect of Gonadotropin-Releasing Hormone Antagonist on Risk of Committing Child Sexual Abuse in Men With Pedophilic Disorder: A Randomized Clinical Trial. Landgren V; Malki K; Bottai M; Arver S; Rahm C JAMA Psychiatry; 2020 Sep; 77(9):897-905. PubMed ID: 32347899 [TBL] [Abstract][Full Text] [Related]
12. Colchicine for acute gout. van Echteld I; Wechalekar MD; Schlesinger N; Buchbinder R; Aletaha D Cochrane Database Syst Rev; 2014 Aug; (8):CD006190. PubMed ID: 25123076 [TBL] [Abstract][Full Text] [Related]
13. Travel Time and Distance and Participation in Precision Oncology Trials at the National Cancer Center Hospital. Uehara Y; Koyama T; Katsuya Y; Sato J; Sudo K; Kondo S; Yoshida T; Shoji H; Shimoi T; Yonemori K; Yamamoto N JAMA Netw Open; 2023 Sep; 6(9):e2333188. PubMed ID: 37713200 [TBL] [Abstract][Full Text] [Related]
14. A self-management programme to reduce falls and improve safe mobility in people with secondary progressive MS: the BRiMS feasibility RCT. Gunn H; Andrade J; Paul L; Miller L; Creanor S; Stevens K; Green C; Ewings P; Barton A; Berrow M; Vickery J; Marshall B; Zajicek J; Freeman J Health Technol Assess; 2019 Jun; 23(27):1-166. PubMed ID: 31217069 [TBL] [Abstract][Full Text] [Related]
15. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs. Colditz GA Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580 [TBL] [Abstract][Full Text] [Related]